News
![blood_cells1 1024x576](https://pharmaphorum.com/wp-content/uploads/2017/12/blood_cells1-1024x576.jpg)
ASH roundup: late breakers take the stage
The final day of the ASH congress always includes a session on late-breaking studies, and this year was no exception, with presentations on Novartis' iptacopan in paroxysmal nocturnal haemo